tradingkey.logo
tradingkey.logo
Search

Celldex Therapeutics Inc

CLDX
Add to Watchlist
38.060USD
-0.425-1.10%
Close 07-31 16:00ETQuotes delayed by 15 min
2.99BMarket Cap
LossP/E TTM

CLDX Financials

See Celldex Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Celldex Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-1.18/-1.14
Revenue / Forecast
15.00K/972.22K
Period
FY2025 Earnings
Revenue(YoY)
1.54M
-77.99%
EPS(YoY)
-3.90
-58.91%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-45.86%-1.18
-72.36%-1.22
-58.87%-1.01
-57.03%-0.85
-45.42%-0.81
14.69%-0.71
21.52%-0.64
15.89%-0.54
10.38%-0.56
-48.01%-0.83
---0.81
---0.65
---0.62
---0.56
----
----
----
----
----
----
Revenue
-97.84%15.00K
-89.70%121.00K
-100.00%0.00
-70.78%730.00K
345.51%695.00K
-71.56%1.18M
110.35%3.19M
832.09%2.50M
-83.87%156.00K
156.11%4.13M
272.73%1.52M
64.42%268.00K
455.75%967.00K
382.93%1.61M
166.01%407.00K
-95.32%163.00K
-74.60%174.00K
-91.18%334.00K
-77.10%153.00K
1374.58%3.48M
Net Profit
-46.27%-78.69M
-72.68%-81.32M
-59.17%-67.04M
-57.92%-56.60M
-63.97%-53.80M
-8.74%-47.09M
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.50M
-27.38%-29.36M
-31.46%-26.49M
-30.96%-26.78M
-169.23%-36.00M
-39.38%-23.05M
8.00%-20.15M
-43.79%-20.45M
-21.23%-13.37M
Net Margin
-6676.97%-524566.67%
-1576.82%-67204.13%
----
-440.37%-7753.42%
63.19%-7740.43%
-282.31%-4007.83%
47.66%-1319.99%
87.39%-1434.83%
-592.65%-21030.77%
36.16%-1048.32%
---2522.08%
---11381.34%
---3036.30%
---1642.10%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
--0.00%
----
----
----
----
----
----
Revenue
-97.84%15.00K
-89.70%121.00K
-100.00%0.00
-70.78%730.00K
345.51%695.00K
-71.56%1.18M
110.35%3.19M
832.09%2.50M
-83.87%156.00K
156.11%4.13M
272.73%1.52M
64.42%268.00K
455.75%967.00K
382.93%1.61M
166.01%407.00K
-95.32%163.00K
-74.60%174.00K
-91.18%334.00K
-77.10%153.00K
1374.58%3.48M
Operating profit
-34.58%-84.44M
-55.56%-87.15M
-41.23%-73.62M
-37.87%-63.86M
-54.50%-62.74M
-59.50%-56.03M
-26.40%-52.13M
-39.49%-46.32M
-25.06%-40.61M
-25.97%-35.13M
-48.90%-41.24M
-19.78%-33.20M
-36.47%-32.47M
-35.46%-27.89M
-44.06%-27.70M
-110.30%-27.72M
-47.27%-23.79M
-100.57%-20.59M
-40.53%-19.23M
-1.42%-13.18M
Net Profit
-46.27%-78.69M
-72.68%-81.32M
-59.17%-67.04M
-57.92%-56.60M
-63.97%-53.80M
-8.74%-47.09M
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.50M
-27.38%-29.36M
-31.46%-26.49M
-30.96%-26.78M
-169.23%-36.00M
-39.38%-23.05M
8.00%-20.15M
-43.79%-20.45M
-21.23%-13.37M
Current assets
-33.81%459.22M
-28.44%534.66M
-22.41%604.34M
-20.14%648.40M
-16.95%693.76M
73.08%747.16M
216.69%778.84M
206.61%811.98M
188.44%835.32M
35.88%431.69M
-26.50%245.93M
-28.03%264.82M
-25.88%289.60M
-22.67%317.69M
-21.56%334.60M
119.55%367.98M
115.26%390.70M
107.66%410.84M
110.20%426.56M
-19.80%167.61M
Total current liabilities
60.76%51.47M
29.09%50.99M
44.78%46.47M
19.18%32.96M
21.78%32.02M
26.91%39.50M
15.29%32.09M
76.77%27.66M
72.75%26.29M
67.25%31.13M
70.91%27.84M
-47.76%15.65M
4.53%15.22M
12.60%18.61M
14.89%16.29M
106.72%29.95M
-14.24%14.56M
16.35%16.53M
16.20%14.18M
33.64%14.49M
Total assets
-30.86%511.25M
-26.42%582.98M
-21.23%648.44M
-18.12%692.41M
-14.89%739.47M
70.17%792.34M
193.72%823.18M
182.51%845.59M
167.73%868.85M
32.00%465.63M
-24.10%280.26M
-25.72%299.31M
-23.47%324.52M
-20.67%352.74M
-19.77%369.23M
97.00%402.96M
93.57%424.04M
88.54%444.65M
79.93%460.20M
-21.75%204.55M
Total liabilities
50.80%55.03M
23.12%55.82M
34.35%50.08M
15.89%37.00M
20.69%36.49M
24.36%45.34M
11.14%37.27M
46.63%31.93M
38.82%30.23M
37.41%36.46M
40.86%33.54M
-42.50%21.77M
-16.04%21.78M
5.37%26.53M
1.37%23.81M
70.05%37.87M
4.18%25.94M
-4.92%25.18M
-8.94%23.49M
-3.00%22.27M
Total equity
-35.10%456.23M
-29.43%527.16M
-23.86%598.36M
-19.45%655.41M
-16.17%702.98M
74.06%747.00M
218.54%785.90M
193.17%813.66M
177.01%838.61M
31.57%429.17M
-28.57%246.72M
-23.98%277.54M
-23.95%302.74M
-22.24%326.20M
-20.91%345.42M
100.29%365.09M
105.03%398.10M
100.36%419.48M
89.90%436.71M
-23.55%182.28M
Net operating income
-20.63%-65.59M
-96.88%-63.94M
12.12%-48.63M
-50.05%-44.01M
-33.80%-54.37M
0.18%-32.48M
-191.35%-55.34M
-7.84%-29.33M
-42.25%-40.64M
-49.49%-32.53M
46.03%-18.99M
-22.26%-27.20M
-16.45%-28.57M
-49.85%-21.76M
-114.95%-35.19M
-86.45%-22.24M
-35.67%-24.53M
-178.70%-14.52M
-38.03%-16.37M
-6.31%-11.93M
Net investment
67.91%72.12M
130.49%55.42M
27.41%60.85M
206.69%49.85M
113.63%42.95M
114.05%24.05M
310.08%47.76M
-4114.00%-46.72M
-699.61%-315.21M
-648.36%-171.16M
-49.51%11.65M
-95.40%1.16M
406.45%52.57M
264.76%31.21M
110.17%23.07M
281.72%25.28M
-76.13%10.38M
-161.40%-18.94M
-433.54%-226.79M
87.18%-13.91M
Net financing
61.88%327.00K
249.48%1.35M
-37.53%774.00K
-98.30%63.00K
-99.95%202.00K
-99.82%386.00K
382.10%1.24M
2690.98%3.71M
62740.35%436.11M
15482.37%217.37M
-88.86%257.00K
87.32%133.00K
128.29%694.00K
227.46%1.40M
-99.15%2.31M
384.00%71.00K
310.81%304.00K
868.18%426.00K
5954.26%271.90M
-100.02%-25.00K

FAQs

What is the total revenue of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its total revenue reached 1.54M, with a year-on-year change of 7.02M.

What are the current assets of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its current assets were 534.66M, with a year-on-year change of -28.44.

What are the total assets of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its total assets of Celldex Therapeutics Inc were 582.98M, with a year-on-year change of -26.42.

What are the total liabilities of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its total liabilities of Celldex Therapeutics Inc were 55.82M, with a year-on-year change of 23.12.

What is the total equity of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its total equity of Celldex Therapeutics Inc was 527.16M, with a year-on-year change of -29.43.

What is the net operating income of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its net operating income of Celldex Therapeutics Inc was -287.37M, with a year-on-year change of -47.31.

What is the net investment of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its net investment of Celldex Therapeutics Inc was 209.07M, with a year-on-year change of 172.06.

What is the net financing of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its net financing of Celldex Therapeutics Inc was 2.39M, with a year-on-year change of -99.46.

What is the Earnings Per Share (EPS) of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.90, with a year-on-year change of -58.91.

What is the net income of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its net income was -258.76M, with a year-on-year change of -63.91.

What is the net margin of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its net profit margin was -16748.03, with a year-on-year change of -644.77.

What is the Return on Equity (ROE) of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -40.62, with a year-on-year change of -51.31.

What is the Return on Assets (ROA) of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.63, with a year-on-year change of -49.93.

What is the operating profit of Celldex Therapeutics Inc?

According to Celldex Therapeutics Inc's FY2025 earnings report, its operating profit was -287.37M, with a year-on-year change of -47.31.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.